Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/IRLA/Net margin

Quince Therapeutics, Inc. (IRLA) Net margin

Quince Therapeutics, Inc. (IRLA) net profit margin by fiscal year — reported net income divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to IRLA

Source: SEC XBRL filings · For reference only · Not investment advice

More IRLA financial trends

IRLA RevenueIRLA Net incomeIRLA Gross profitIRLA Gross marginIRLA Operating incomeIRLA Operating marginIRLA Operating cash flowIRLA Free cash flowIRLA Capital expendituresIRLA Return on equityIRLA Stock buybacksIRLA Dividends paidIRLA Total assetsIRLA Total liabilitiesIRLA Shareholders’ equityIRLA overview →